Company / Operating Income per Share
IOVANCE BIOTHERAPEUTICS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.32
FY2025
5-year range
-$2504.59 / -$1.32
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#96 of 201
Health Care
What the data says
At $-1.32, IOVANCE BIOTHERAPEUTICS, INC.'s operating income per share ranks #96 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-2504.59 in FY2022 to $-1.32 in FY2025.
Based on SEC 10-K filings.
-1.32 in FY2025.
Improved from $-2.45 to $-1.32 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 201 in Health CareTop 48% of 201This company -$1.32 Sector average -$3.23
▼
+59.1% above sector average
Key checks
Key Insights
- IOVANCE BIOTHERAPEUTICS, INC.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 14.4% year-over-year.
- Ranks #96 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.32 | +14.4% |
| FY2024 | -$1.54 | +37.1% |
| FY2023 | -$2.45 | +99.9% |
| FY2022 | -$2504.59 | -12.1% |
| FY2021 | -$2233.96 | -18.0% |
| FY2020 | -$1893.96 | -13.8% |
| FY2019 | -$1663.81 | -94812.5% |
| FY2018 | -$1.75 | -17.5% |
| FY2017 | -$1.49 | -501.6% |
| FY2016 | -$0.25 | +63.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026